Literature DB >> 29071043

Migraine headache in patients with idiopathic intracranial hypertension.

Farzad Sina1, Saeed Razmeh1, Neda Habibzadeh1, Arefeh Zavari1, Mona Nabovvati1.   

Abstract

Migraine is a neurological disorder that afflicts many people in the world and can cause severe disability during the attacks. The pathophysiology of migraine is complex and not fully understood. It seems that migraine is common in idiopathic intracranial hypertension (IIH). However, the association between migraine headache and IIH is still unclear. The present study was conducted to assess the prevalence of migraine headache and associated factors in IIH patients. In this cross-sectional study, a total of 68 patients diagnosed with IIH underwent a medical history interview and a neurological examination. The diagnosis of migraine was based on the four diagnostic criteria of the International Classification of Headache Disorders 3rd edition. Forty-five patients (63.2%) met the diagnostic criteria of migraine headache. There was no significant difference between patients with and without migraine headache in respect of their age, gender, body mass. This study revealed high prevalence of migraine headache in IIH patients; appropriate treatment can reduce their headache and prevent unnecessary treatments for IIH.

Entities:  

Keywords:  Idiopathic intracranial hypertension; Migraine headache; Neurological disorder

Year:  2017        PMID: 29071043      PMCID: PMC5641834          DOI: 10.4081/or.2017.7280

Source DB:  PubMed          Journal:  Neurol Int        ISSN: 2035-8385


Introduction

Migraine is one of the most common cause of headache and consultation for headache in America, South-East Asia, Europe, and the Western Pacific. The mechanism and pathophysiology of migraine is complex and it is related to environmental and genetic factores.[1,2] It afflicts many people in the world and after puberty is more prevalent in women. The symptoms associated with migraine headache include headache that usually is pulsatile and unilateral, nausea and vomiting, vertigo, photophobia and phonophobia and in migraine with aura, it can associated with visual, sensory, motor and speech symptoms.[3-5] Idiopathic intracranial hypertension (IIH) presents with headache, diplopia due to cranial nerve palsy, visual obscuration, tinnitus and papilledema with normal cerebrospinal fluid (CSF) analysis and neuroimaging.[6,7] Many of this patient after treatment complain of headache without any abnormality in optic disc and CSF pressure. In present study, we assessed the prevalence of migraine in patients with IIH as common cause of headache.

Materials and Methods

This cross-sectional study was done in neurology ward of Rasoul-Akram Hospitals affiliated with the Iran University of Medical Sciences, Tehran, Iran. The study was approved by the Ethical Committee of the University. The study population included the patients with intracranial hypertension (IIH) whose disease was under control and without papilledema and raised of CSF pressure. They were interviewed in the neurology clinic. The patients who had uncontrolled diseases, sinus vein thrombosis were excluded. All participants signed a written informed consent. The diagnosis of migraine headache in the patients was based on the four diagnostic criteria of the International Classification of Headache Disorders 3rd edition.[8,9] After making the diagnosis of migraine headache, the IIH patients were divided into two groups: those with and without migraine. The Clinical characteristics assessed in both groups were age, gender, duration of disease, BMI index, and family history of migraine. Body weight and height of all participants was obtained from her/his information and BMI was calculated as weight in kilograms divided by the square of height in meter. SPSS 22 was used for statistical analyses and P<0.05 was considered as a significant level. Descriptive statistics including mean and standard deviation (SD) were used to characterize the study population and t-student test were used for comparing quantitative variable between two groups.

Results

The 68 patients known case of IIH were studied, 11 males (16.2%) and 57 females (83.8%). The age range was 9-63 years. the mean age was 33.99 years. The mean BMI of the all patients was 28.6±4.4 kg/m2 and the duration of 71% of IIH patients was under 5 years, 21% between 5-10 years and 8% above the 10 years. The 45 patients (63.4%) out of a total of 68 subjects diagnosed with IIH met the migraine diagnostic criteria. There were 37 women (82.2%) and 8 men (17.8%). The mean age was 34.8±12.02 years, and the mean BMI was 28.4±4.2 kg/m2. In migraine population, 75% of had the disease duration under 5 years and 17.8% between 5-10 years and others above the 10 years. The family history of migraine in patients with migraine headache was 68%. The 23 patients [women20 (86.9%) and 3 men (13.1%)] were without migraine headache. The mean age was 33.3. The mean BMI in this patient’s was 29 kg/m2 (Table 1) and the disease duration was 61% under 5 years and 38% between 5-10 years and 1% above the 10 years. The family history of migraine in this patient was 62%. In patients with migraine headache, 33% had headache more in frontal, 16% occipital and other had generalized. 51 percent had moderate chronic daily headache and only 5 patients had migraine with aura.
Table 1.

Overall information about the patients studied.

Signs and symptomsOverall patientsWith migraineWithout migraine
Mean ages (years)33.9934.833
Female (n)57 (83.8%)37 (82.2%)20 (86.9%)
Male (n)11 (16.2%)8 (17.8%)3 (13.1%)
BMI (kg/m2)28.628.429
Family history of migraine (%)656862

BMI, body mass index.

Discussion

The migraine headache is a common disorder in IIH patients. In our study, there is significant association between the incidence of IIH and migraine headache and the prevalence of migraine was 63.2%. However, evaluation of the association between IIH and migraine headache needs a case control study which compare the migraine prevalence between patients and general population that present study lacks control group. In our study, no differences were found between groups with and without migraine headache in their age, gender and body max index (P>0.05). In study by Kathleen et al., that assessed the clinical characteristics of IIH patients with and without papilledema, shows that the prevalence of migraine headache in patients without papilledema was 65% and in patients with papilledema was 45%.[10] Curiously there is relation between migraine and intracranial hypertension that is very complex and need more study. Mathew et al. assessed the prevalence of intracranial pressure in patients with chronic unresponsive migraine headache, in this study 44 patients with chronic migraine headache and stenosis in sinus vein in mri venography were assessed that 86.4% of this patients have raised intracranial hypertension (csf pressure >200 mmH2O). The 77% of this patient, experience decreased headache with treatment of ICP raising.[10] In another study by Ramadan that assessed the IIH in the patients with chronic daily headache, 12 patients have intracranial hypertension that do not have any evidence of papilledema, visual obscuration and decreased visual acuity and the treatment with acetazolamide reduce their chronic headache.[11] However, it seems that in any patients with chronic migraine headache that is refractory and do not respond to usual prophylactic migraine headache, it is essential that done spinal tap for rule out of idiopathic intracranial hypertension without papilledema.[12] In our study obesity was frequent in IIH patients with and without migraine, the relation between obesity and IIH remains unclear. It is seem that Healthy overweight individuals may have CSF pressure above the normal range and also the obesity associated with increased severity and frequency of migraine attacks.[13]

Conclusions

In conclusion, as mentioned earlier there is a high prevalence of migraine headache in patients with IIH, and in any patients with IIH who complain of headache after treatment, migraine headache should considered. Appropriate treatment can improve their quality of life and prevent unnecessary treatments for IIH.
  10 in total

Review 1.  Sex-related differences in epidemiological and clinic-based headache studies.

Authors:  E Anne Macgregor; Jason D Rosenberg; Tobias Kurth
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

2.  The International Classification of Headache Disorders, 3rd edition (beta version).

Authors: 
Journal:  Cephalalgia       Date:  2013-07       Impact factor: 6.292

3.  Coexistence of migraine and idiopathic intracranial hypertension without papilledema.

Authors:  N T Mathew; K Ravishankar; L C Sanin
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

Review 4.  New therapeutic approaches for the prevention and treatment of migraine.

Authors:  Hans-Christoph Diener; Andrew Charles; Peter J Goadsby; Dagny Holle
Journal:  Lancet Neurol       Date:  2015-10       Impact factor: 44.182

5.  Obesity and migraine: a population study.

Authors:  Marcelo E Bigal; Joshua N Liberman; Richard B Lipton
Journal:  Neurology       Date:  2005-12-14       Impact factor: 9.910

6.  Migraine prevalence by age and sex in the United States: a life-span study.

Authors:  T W Victor; X Hu; J C Campbell; D C Buse; R B Lipton
Journal:  Cephalalgia       Date:  2010-03-12       Impact factor: 6.292

7.  Epidemiology of chronic daily headache.

Authors:  I Kavuk; A Yavuz; U Cetindere; M W Agelink; H C Diener
Journal:  Eur J Med Res       Date:  2003-06-30       Impact factor: 2.175

8.  Intracranial hypertension and migraine.

Authors:  N M Ramadan
Journal:  Cephalalgia       Date:  1993-06       Impact factor: 6.292

9.  A comparison of idiopathic intracranial hypertension with and without papilledema.

Authors:  Kathleen B Digre; Beau K Nakamoto; Judith E A Warner; Wendy J Langeberg; Susan K Baggaley; Bradley J Katz
Journal:  Headache       Date:  2009-02       Impact factor: 5.887

10.  Intracranial pressure in unresponsive chronic migraine.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Paolo Cappabianca; Mario Quarantelli; Felice Esposito; Giuseppe Cardillo; Vincenzo Bonavita
Journal:  J Neurol       Date:  2014-04-30       Impact factor: 4.849

  10 in total
  8 in total

Review 1.  Part 2: Bypassing TBI-Metabolic Surgery and the Link Between Obesity and Traumatic Brain Injury-A Review.

Authors:  T W McGlennon; J N Buchwald; Walter J Pories; Fang Yu; Arthur Roberts; Eric P Ahnfeldt; Rukmini Menon; Henry Buchwald
Journal:  Obes Surg       Date:  2021-01-06       Impact factor: 4.129

Review 2.  Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine.

Authors:  Roberto De Simone; Angelo Ranieri; Mattia Sansone; Enrico Marano; Cinzia Valeria Russo; Francesco Saccà; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2019-05       Impact factor: 3.307

3.  The prevalence of papilledema in patients with migraine: a crucial cooccurrence of migraine and idiopathic intracranial hypertension.

Authors:  Halil Onder; Ersin Kasim Ulusoy; Memet Aslanyavrusu; Tulin Akturk; Guven Arslan; Ibrahim Akkurt; Erol Erkan
Journal:  Neurol Sci       Date:  2020-05-26       Impact factor: 3.307

4.  Emergency department utilization among individuals with idiopathic intracranial hypertension.

Authors:  Sean Murphy; Daniel L Friesner; Robert Rosenman; Carin S Waslo; Johnathan Au; Emanuel Tanne
Journal:  Int J Health Care Qual Assur       Date:  2019-02-11

5.  Telemedicine for neuro-ophthalmology: challenges and opportunities.

Authors:  Yin Allison Liu; Melissa W Ko; Heather E Moss
Journal:  Curr Opin Neurol       Date:  2021-02-01       Impact factor: 6.283

Review 6.  Advances in the understanding of headache in idiopathic intracranial hypertension.

Authors:  Susan P Mollan; Jan Hoffmann; Alexandra J Sinclair
Journal:  Curr Opin Neurol       Date:  2019-02       Impact factor: 5.710

7.  Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria.

Authors:  Romina Moavero; Giorgia Sforza; Laura Papetti; Barbara Battan; Samuela Tarantino; Federico Vigevano; Massimiliano Valeriani
Journal:  Front Neurol       Date:  2018-09-28       Impact factor: 4.003

8.  Idiopathic Intracranial Hypertension: The Monster Within.

Authors:  Aastha Takkar; Vivek Lal
Journal:  Ann Indian Acad Neurol       Date:  2020-02-25       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.